The cysteine protease ApdS from Streptococcus suis promotes evasion of innate immune defenses by cleaving the antimicrobial peptide cathelicidin LL-37. [PDF]
J Biol Chem, 2019 Xie F +10 more
europepmc +1 more source
Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications. [PDF]
J Nanobiotechnology, 2020 Wnorowska U +8 more
europepmc +1 more source
Immunomodulatory Functions of the Human Cathelicidin LL-37 (aa 13-31)-Derived Peptides are Associated with Predicted α-Helical Propensity and Hydrophobic Index. [PDF]
Biomolecules, 2019 Hemshekhar M +4 more
europepmc +1 more source
Cathelicidin LL-37: mechanisms of action and research progress
Infectious Diseases ResearchZi-Ting Zhang +2 more
openaire +1 more source
Cathelicidin LL-37 Affects Surface and Intracellular Toll-Like Receptor Expression in Tissue Mast Cells. [PDF]
J Immunol Res, 2018 Agier J +5 more
europepmc +1 more source
Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13. [PDF]
Sci Rep, 2017 Niemirowicz K +8 more
europepmc +1 more source
Retraction Note: Human cathelicidin LL-37 enhance the antibiofilm effect of EGCG on Streptococcus mutans. [PDF]
BMC Oral Health, 2017 Guo YJ, Zhang B, Feng XS, Ren HX, Xu JR.
europepmc +1 more source
Carbon Nanoparticles Inhibit the Antimicrobial Activities of the Human Cathelicidin LL-37 through Structural Alteration. [PDF]
J Immunol, 2017 Findlay F +7 more
europepmc +1 more source
Anaerobic bacteria growth in the presence of cathelicidin LL-37 and selected ceragenins delivered as magnetic nanoparticles cargo. [PDF]
BMC Microbiol, 2017 Durnaś B +8 more
europepmc +1 more source